Research & Product Development
The Press invites proposals from non-student investigators for research and development on the Minnesota Multiphasic Personality Inventory (MMPI) and Multidimensional Personality Questionnaire (MPQ) instruments.
The Press seeks applications that consider the enrollment of people/persons of color or communities of color and lesbian, gay, bisexual, transgender, intersex, queer/questioning, and asexual (LGBTIQA+) individuals toward the goal of increasing generalization of results and improving assessment of diverse individuals and/or groups, especially as they relate to the research and product development priorities listed below. Additionally, the Press seeks applications from people/persons of color and LGBTIQA+ principal investigators as well as projects that include diverse individuals on their research team.
Only one proposal per investigator will be considered, unless the Press has expressly invited specific proposals for product development.
RESEARCH
Priority will be given to studies that:
- focus on assessment of racial and ethnic minorities, gender minorities, and other under-represented populations using the MMPI-3 and the MMPI-A-RF
- focus on the U.S. Spanish translations of the MMPI-3 and MMPI-A-RF
- focus on use of the MMPI-3 with active-duty and veteran military personnel; assessment of psychiatric inpatients; predict outcomes in employment screening; examine MMPI-3 use in various forensic assessments (e.g., trial competency, criminal responsibility, risk assessment, personal injury/disability assessments, family court applications such as child custody and parental fitness evaluations); assessment of response bias in various settings; treatment planning or outcome prediction in mental health or medical settings; assessment of personality disorders and, in particular, psychopathy.
- validate the MMPI-A-RF in a variety of settings and with various criterion measures. In addition to replicating the findings reported in the MMPI-A-RF manual (psychiatric inpatient, residential treatment, and forensic settings) with similar or expanded criterion measures, data should be collected in medical, neuropsychological, outpatient mental health, and school settings. Archival data studies with adequate criterion measures will also be considered.
- use the soon to be published version of the MPQ to address test use with preemployment screening of public safety personnel as well as other applications of the instrument.
These have been identified as research priorities. However, we do not wish to discourage the submission of proposals in other areas of MMPI-3, MMPI-A-RF, and MPQ research that investigators have an interest in exploring.
PRODUCT DEVELOPMENT
The Press invites proposals for:
- further validation of the Spanish-language translation of the MMPI-3
- development of the MMPI-3 product line, including addition of comparison groups representing use of the MMPI-3 in a broad range of settings
- further development of the soon to be published MPQ test product line, including addition of comparison groups representing use of the MPQ in a broad range of settings
Submission Process
Requests should be submitted using the attached forms:
When completing the forms, please provide thorough and detailed responses. Requests will be formally reviewed by the Test Division’s Advisory Board and assessed for the quality of the proposal and the importance of the proposed research/development. The advisors will be asked to comment on the strengths and/or weaknesses of new proposals and on the progress reported on requests for renewal funding of previously supported research.
Please submit requests using the above downloadable forms to Katie Nickerson, Test Division Manager, at nickerso@umn.edu no later than Friday, April 14, 2023.
If you received funding in 2022-2023 from the Press, please submit progress and expenditure reports using the downloadable forms found below to Katie Nickerson, Test Division Manager, at nickerso@umn.edu. Note that progress reports must be received before funding requests for 2023/2024 are considered.
Research Progress Report (due April 14): ( Word | PDF)
Product Development Progress Report (due April 14): (Word | PDF )
Final Expenditure Reports (due July 3): (Word | PDF)